90Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide

Overview of attention for article published in Journal of Clinical Oncology, March 2010

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

blogs: 2 blogs
policy: 1 policy source
patent: 1 patent

wikipedia: 2 Wikipedia pages
guideline: 5 clinical guideline sources

Readers on

mendeley: 93 Mendeley

So far, Altmetric has seen 7 Guidelines that reference this research output.

Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

Clinical guideline published by European Society for Medical Oncology (ESMO) on 19 Jan 2021

The European Society for Medical Oncology (ESMO) is a leading organization dedicated to advancing cancer care through education, research, and clinical practice guidelines. It provides a professional network for oncologists, offering resources like clinical practice guidelines, educational courses, and access to oncology journals.

Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up † † Approved by the ESMO Guidelines Committee: August 2007, last update March 2020. This publication supersedes the previously published version—Ann Oncol. 2012;23(suppl 7):vii124–vii130.

Clinical guideline published by European Society for Medical Oncology (ESMO) on 06 Apr 2020

ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site

Clinical guideline published by European Neuroendocrine Tumor Society (ENETS) on 05 Jan 2016

Founded in 2004, ENETS is the leading and longest-established society dedicated to Neuroendocrine Tumours, with over 1,500 members from diverse medical disciplines.

ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors

Clinical guideline published by European Neuroendocrine Tumor Society (ENETS) on 05 Jan 2016

Founded in 2004, ENETS is the leading and longest-established society dedicated to Neuroendocrine Tumours, with over 1,500 members from diverse medical disciplines.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity, including 3 additional posts.